MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about press release

16 Aug 2021 Evaluate

In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that it enclosed a copy of the Press Release on the Unaudited Financial results of the Company for the quarter ended 30th June, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1751.80
Dr. Reddys Labs. 1235.60
Cipla 1327.60
Lupin 1960.00
Zydus Lifesciences 1124.35
View more..